Globus Medical Inc Quick Ratio (GMED) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Globus Medical Inc   (NYSE: GMED)

Globus Medical Inc 's Quick Ratio

GMED's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 1.02 below Globus Medical Inc average.

Within Medical Equipment & Supplies industry 103 other companies have achieved higher Quick Ratio than Globus Medical Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 992 to 1635.

Explain Quick Ratio?
How much Cash & cash equivalents GMED´s has?
What are GMED´s Current Liabilities?




GMED Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 9.01 % 228.46 % 25.41 % -38.34 % -43.04 %
Y / Y Cash & cash equivalent Change 2659.06 % - - 427.6 % -73.93 %
Quick Ratio MRQ 1.02 1.24 1.31 1.06 0.04
GMED's Total Ranking # 1635 # 992 # 1254 # 2895 #
Seq. Current Liabilities Change 5.96 % -0.65 % -8.58 % 13.26 % 219.28 %
Seq. Cash & cash equivalent Change -13.06 % -5.51 % 13.03 % 2871.33 % -



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 104
Healthcare Sector # 594
Overall Market # 1635


Quick Ratio Statistics
High Average Low
5.73 2.64 0.04
(Sep 30 2012)   (Sep 30 2025)




Financial Statements
Globus Medical Inc 's Current Liabilities $ 508 Millions Visit GMED's Balance sheet
Globus Medical Inc 's Cash & cash equivalent $ 517 Millions Visit GMED's Balance sheet
Source of GMED's Sales Visit GMED's Sales by Geography


Cumulative Globus Medical Inc 's Quick Ratio

GMED's Quick Ratio for the trailling 12 Months

GMED Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 7.83 % -11.3 % -43.14 % -53.16 % -34.33 %
Y / Y Cash & cash equivalent TTM Growth 1749.01 % 914.31 % 363.67 % 69.17 % -56.41 %
Quick Ratio TTM 1.15 0.92 0.74 0.38 0.07
Total Ranking TTM # 3988 # 3000 # 2518 # 3097 #
Seq. Current Liabilities TTM Growth 2.15 % 20.55 % 6.41 % -17.72 % -15.97 %
Seq. Cash & cash equivalent TTM Growth 27.69 % 49.35 % 109.35 % 363.12 % -29.95 %


On the trailing twelve months basis GMED Cash & cash equivalent more than doubled by 2659.06 % in Q3 2026 year on year, faster than Current Liabilities, this led to increase in in Globus Medical Inc 's Quick Ratio to 1.15, Quick Ratio remained below GMED average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 203 other companies have achieved higher Quick Ratio than Globus Medical Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3000 to 3988.

Explain Quick Ratio?
How much Cash & cash equivalents GMED´s has?
What are GMED´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 204
Healthcare Sector # 899
Within the Market # 3988


trailing twelve months Quick Ratio Statistics
High Average Low
5.43 1.58 0.3
(Dec 31 2012)   (Dec 31 2025)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Pulse Biosciences Inc   2.74 $ 36.725  Millions$ 13.395  Millions
Staar Surgical Co  2.73 $ 206.414  Millions$ 75.541  Millions
Medinotec Inc   2.68 $ 2.584  Millions$ 0.963  Millions
Glaukos Corp  2.66 $ 337.478  Millions$ 126.726  Millions
Pulmonx Corporation  2.57 $ 53.245  Millions$ 20.739  Millions
Beta Bionics Inc   2.48 $ 81.551  Millions$ 32.836  Millions
Irhythm Holdings Inc   2.46 $ 560.719  Millions$ 228.025  Millions
Genedx Holdings Corp   2.38 $ 170.118  Millions$ 71.403  Millions
Apyx Medical Corp  2.37 $ 25.777  Millions$ 10.870  Millions
Atricure Inc   2.23 $ 187.031  Millions$ 83.972  Millions
Inspire Medical Systems inc   1.96 $ 190.803  Millions$ 97.438  Millions
Merit Medical Systems Inc  1.90 $ 503.551  Millions$ 265.083  Millions
Nephros Inc   1.89 $ 4.546  Millions$ 2.409  Millions
Warby Parker Inc   1.77 $ 287.914  Millions$ 162.226  Millions
Anika Therapeutics Inc   1.68 $ 44.957  Millions$ 26.725  Millions
EBR Systems, Inc.  1.63 $ 85.415  Millions$ 52.539  Millions
Intuitive Surgical Inc   1.60 $ 4,042.500  Millions$ 2,533.000  Millions
Tactile Systems Technology Inc   1.58 $ 75.110  Millions$ 47.499  Millions
Edap Tms Sa  1.56 $ 56.269  Millions$ 36.070  Millions
Neuraxis Inc   1.55 $ 4.477  Millions$ 2.888  Millions
Envista Holdings Corporation  1.42 $ 1,158.800  Millions$ 816.300  Millions
Inogen Inc   1.38 $ 96.840  Millions$ 70.265  Millions
Si bone inc   1.20 $ 35.460  Millions$ 29.619  Millions
Medline Inc   1.12 $ 3,608.000  Millions$ 3,211.000  Millions
Pro dex Inc   1.10 $ 14.219  Millions$ 12.884  Millions
Penumbra Inc  1.09 $ 254.282  Millions$ 233.810  Millions
Establishment Labs Holdings Inc   1.06 $ 75.812  Millions$ 71.611  Millions
Globus Medical Inc   1.02 $ 517.435  Millions$ 507.938  Millions
Envoy Medical Inc   0.98 $ 14.570  Millions$ 14.861  Millions
Integra Lifesciences Holdings Corp  0.95 $ 311.930  Millions$ 329.002  Millions

Date modified: 2026-11-06T12:56:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.